The revenue stands at ₹4,921.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.25 per cent from ₹4,197.00 crore. This corresponds to a year-on-year *(YoY) growth of 54.85 per cent.
Operating Profit stands at ₹1,643.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.36 per cent from ₹1,290.00 crore. This corresponds to a year-on-year *(YoY) growth of 59.21 per cent.
PBDT stands at ₹1,326.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.87 per cent from ₹1,037.00 crore. This corresponds to a year-on-year *(YoY) growth of 41.21 per cent.
Profit Before Tax stands at ₹733.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 38.56 per cent from ₹529.00 crore. This corresponds to a year-on-year *(YoY) decline of 0.68 per cent.
Net Profit stands at ₹566.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 55.49 per cent from ₹364.00 crore. This represents a 3.28 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Torrent Pharma. | -1.42% | -0.95% | -4.50% | -3.81% | 15.07% | 32.71% |
| Sun Pharma.Inds. | -0.99% | 0.07% | -4.56% | -8.03% | 3.84% | 7.53% |
| Divi's Lab. | 0.37% | 3.99% | 1.03% | 40.65% | 60.80% | 56.23% |
| Zydus Lifesci. | -0.52% | 1.36% | 2.21% | -0.50% | 27.92% | 15.86% |
| Laurus Labs | 0.05% | 4.63% | 6.30% | 36.71% | 89.66% | 136.90% |
| Cipla | -1.01% | -0.34% | -2.81% | -7.78% | 8.60% | -12.10% |
Chairman/ED & CEO : Samir Mehta
ED / MD / Promoter : Aman Mehta
Non-Exec & Non-Independent Dir : Jindal Mehta
Lead Independent Non Executive Director : Manish Choksi
Independent Non Exe. Director : Nayantara Bali
Independent Non Exe. Director : Nikhil Khattau
Company Sec. & Compli. Officer : Chintan M. Trivedi
Chairman Emeritus : Sudhir Mehta